human
polyomaviru
jc
common
agent
infect
major
popul
persist
kidney
caus
disord
healthi
host
immunosuppress
subject
particular
hiv
patient
jc
viru
jcv
caus
progress
multifoc
leukoencephalopathi
pml
fatal
diseas
central
nervou
system
cn
due
lytic
infect
oligodendrocyt
involv
jcv
induct
cn
tumor
also
demonstr
mechan
jcv
pathogenesi
still
repres
controversi
issu
p
ferrant
milano
describ
studi
investig
role
major
capsid
protein
untransl
transcript
control
region
tcr
wherea
primari
determin
viral
entri
differ
rearrang
tcr
genom
region
target
neurotrop
transcript
factor
seem
link
jcv
pathogenesi
viru
parvoviru
caus
aplast
anemia
adult
fetal
abnorm
pregnanc
studi
interact
vitro
model
develop
investig
kinet
viru
transcript
replic
permiss
cell
line
f
bonvicini
bologna
synthesi
viral
mrna
preced
replic
viral
genom
pcr
maximum
amount
mrna
detect
h
peak
viral
dna
synthesi
h
western
blot
ifi
analysi
document
viral
protein
accumul
h
elucid
restrict
host
cell
tropism
viru
delbarba
bologna
describ
function
dissect
genom
clone
permiss
cell
line
result
obtain
construct
indic
structur
gene
express
without
dna
replic
delbarba
suggest
addit
function
function
need
replic
viru
fm
buonaguro
napoli
provid
epidemiolog
evid
italian
popul
variant
oncogen
european
variant
observ
remark
implic
underlin
need
variant
identif
develop
specif
vaccin
optim
diagnost
protocol
abil
oncoprotein
inhibit
death
apoptosi
inhibit
caspas
activ
describ
cirilli
roma
ar
ciccaglion
roma
describ
effect
hcv
protein
express
cell
line
hcv
protein
express
induc
inhibit
progress
mechan
involv
activ
endoplasm
reticulum
pathway
alter
cyclin
e
rna
protein
level
l
rubino
bari
discuss
mechan
replic
tombusviru
subvir
rna
yeast
cell
subvir
rna
satellit
rna
satrna
defect
interf
rna
di
rna
depend
entir
helper
viru
genom
replic
show
satrna
replic
strategi
differ
genom
di
rna
requir
presenc
genom
act
enhanc
pistello
pisa
discuss
intim
connect
viru
evolut
persist
host
develop
immun
system
abl
attack
virus
viral
infect
cell
hand
virus
develop
strategi
escap
attack
immun
system
extraordinari
abil
virus
elud
immun
surveil
network
allow
viral
persist
host
remark
exampl
worldwid
dissemin
hiv
chronic
diseas
develop
wherea
viru
persist
allow
genet
divers
pathogen
mechan
select
viral
evolut
b
raccah
bet
degan
review
biolog
molecular
aspect
plant
interact
surviv
spread
plant
virus
depend
vector
particular
insect
recent
year
use
molecular
tool
mechan
identifi
allow
interact
persist
virus
vector
understand
hope
grant
us
better
tool
combat
plant
viru
spread
de
milito
stockholm
sweden
describ
studi
investig
serolog
memori
b
cell
dysfunct
chronic
primari
infect
serolog
memori
significantli
reduc
patient
chronic
infect
shown
reduct
memori
b
cell
titer
antibodi
sever
antigen
studi
shed
light
cours
b
cell
dysfunct
primari
infect
emphas
import
acut
infect
establish
b
cell
defect
observ
chronic
infect
patient
g
mangino
roma
analyz
effect
regulatori
protein
nef
induct
rapid
activ
pathway
human
macrophag
vitro
treatment
p
caposio
torino
provid
evid
essenti
role
product
replic
hcmv
inflammatori
respons
endotheli
cell
emphas
feasibl
block
activ
mechan
prevent
inflamm
mv
chiantor
roma
elucid
mechan
progress
human
cervic
carcinoma
cell
cervic
carcinoma
cell
line
although
function
inhibit
hpv
oncoprotein
treatment
induc
cell
death
slow
ruggeri
roma
analyz
effect
hcv
core
protein
express
cell
line
result
show
hcv
core
protein
might
promot
progress
increas
stabil
oncoprotein
result
support
import
role
play
hcv
core
protein
hepatocarcinogenesi
pathogenesi
persist
infect
host
sequenc
variat
bkv
regulatori
region
link
human
polyomaviru
associ
nephropathi
pvan
describ
azzi
firenz
data
suggest
viru
genom
variat
might
play
contributori
role
develop
pvan
variat
neither
suffici
necessari
develop
pvan
f
dal
pozzo
bologna
propos
ovin
system
base
cultur
lamb
keratinocyt
studi
orf
viru
infect
altern
anim
model
orf
viru
epitheliotrop
viru
affect
sheep
goat
human
caus
contagi
ecthyma
model
appli
studi
orf
pathogenesi
search
molecul
antivir
activ
f
di
serio
bari
describ
interfer
peach
latent
mosaic
viroid
pmlv
chloroplast
develop
demonstr
pathogenet
determin
consist
nucleotid
insert
fold
short
steam
cap
tetraloop
present
atyp
plmv
ptlv
variant
probabl
block
earli
critic
step
chloroplast
differenti
session
introduc
lectur
campo
glasgow
discuss
papillomaviru
pv
immunomodul
mechan
viru
persist
limit
pv
replic
cycl
epithelium
togeth
express
viru
protein
absenc
inflamm
minim
viru
exposur
immun
cell
recent
shown
pv
directli
interfer
immun
respons
oncoprotein
respons
interfer
interferon
signal
transduct
mhc
class
addit
pv
inhibit
activ
modul
antigen
present
zipeto
verona
describ
fusion
complex
produc
interact
induc
broad
spectrum
neutral
antibodi
inhibit
entri
tropic
strain
l
buonaguro
napoli
discuss
efficaci
subtyp
particl
strategi
induc
effect
prolong
additivesynergist
immun
ex
vivo
neutral
homolog
well
heterolog
primari
field
isol
suggest
vivo
protect
thu
broaden
spectrum
clade
target
vaccin
strategi
prevent
therapeut
approach
p
isola
pisa
propos
gene
felin
immunodefici
viru
fiv
encod
protein
structur
similar
hiv
tat
could
target
vaccin
develop
result
show
good
humor
cellular
immun
respons
two
month
complet
immun
follow
demonstr
human
cytomegaloviru
hcmv
gene
genet
determin
endotheli
cell
tropism
viru
transfer
leukocyt
lilleri
pavia
describ
experi
demonstr
also
dendrit
cell
tropism
determin
antigen
character
rhesu
rotaviru
surfac
protein
express
escherichia
coli
allow
assess
immunogen
mice
result
would
encourag
studi
evalu
effect
rotaviru
vaccin
monini
roma
capua
padova
review
research
avian
influenza
virus
impact
virus
human
health
discuss
genet
analysi
isol
pandem
infect
centuri
new
strain
certainli
emerg
reassort
viral
gene
avian
human
origin
permiss
host
avian
influenza
virus
shown
infect
human
directli
circumst
coinfect
human
influenza
viru
could
give
rise
genet
reassort
potenti
emerg
viru
fulli
capabl
spread
human
popul
antigen
characterist
human
popul
would
immunolog
rare
event
could
result
true
influenza
pandem
fm
ruggeri
roma
highlight
epidemiolog
foodborn
viru
fbv
infect
emerg
problem
although
fbv
gener
transmit
via
contamin
food
water
environ
recent
research
suggest
fbv
infect
may
also
zoonot
transmiss
either
wild
domest
anim
potenti
risk
introduct
new
strain
human
popul
identif
fbv
reli
upon
detect
genom
nucleic
acid
sequenc
clinic
specimen
food
sampl
gener
fbv
grown
cell
cultur
molecular
identif
difficult
particular
enter
calicivirus
extrem
genom
variabl
virus
ruggeri
also
discuss
import
constant
remodel
molecular
reagent
make
avail
array
effici
diagnost
tool
grant
develop
common
databas
prompt
access
collabor
investig
network
f
pacciarini
milano
describ
studi
sar
coronaviru
replic
show
macrophag
could
product
infect
although
low
effici
epidemiolog
virolog
phylogenet
analys
human
metapneumoviru
hmpv
strain
occour
northern
itali
season
report
g
campanini
pavia
show
differ
type
hmpv
specif
primer
pair
requir
overal
detect
consider
suggest
need
develop
effici
cell
cultur
system
recov
new
type
hmpv
f
maggi
pisa
provid
evid
correl
tt
viru
infect
level
eosinophil
cation
protein
children
acut
respiratori
diseas
find
rais
interest
possibl
activ
ttv
replic
repres
induc
cofactor
pathophysiolog
common
afflict
e
cancellotti
describ
role
prp
glycosyl
normal
function
transmiss
spongiform
encephalopathi
mous
model
risk
xenotransplant
reactiv
anim
virus
caus
xenoinfect
human
recipi
e
caselli
ferrara
provid
evid
interact
reciproc
reactiv
porcin
lymphotrop
human
regard
coinfect
xenotranspl
patient
could
induc
lytic
reactiv
one
virus
possibl
induc
develop
sever
patholog
molecular
character
noroviru
detect
cattl
italian
herd
demonstr
presenc
last
two
differ
lineag
virus
reffer
magnino
pavia
g
mame
sassari
show
evid
absenc
correl
express
multipl
retroviru
presenc
human
multipl
sclerosi
patient
control
c
serra
sassari
analyz
effect
interferon
beta
releas
multipl
sclerosi
ms
retroviru
msvr
plasma
spinal
fluid
sampl
ms
patient
show
releas
extracellular
inhibit
interferon
beta
vivo
vitro
increas
proinflammatori
cytokin
discoveri
new
drug
treatment
hcmv
infect
could
find
impuls
studi
present
loregian
padova
demonstr
overlap
peptid
span
residu
abl
induc
disrupt
interact
hcmv
dna
polymeras
subunit
result
suggest
specif
side
chain
crucial
interact
regard
small
molecul
target
relev
side
chain
could
interfer
interact
inhibit
dna
replic
l
gallina
bologna
report
antivir
activ
cidofovir
candid
therapi
contagi
ecthyma
caus
orf
viru
natur
genet
polymorph
associ
differ
pathway
resist
analogu
discuss
zazzi
siena
propos
differ
genet
background
might
contribut
develop
specif
analogu
resist
pathway
knowledg
along
associ
treatment
histori
resist
mutat
may
help
predict
possibl
avoid
develop
resist
parisi
padova
describ
case
report
fatal
evolut
kaposi
sarcoma
primari
effus
lymphoma
patient
despit
success
antiretrovir
therapi
oral
commun
preval
focus
infect
tagliamont
napoli
discuss
heterosexu
transmiss
subtyp
itali
risk
new
epidem
wave
clade
well
recombin
form
studi
base
modifi
heteroduplex
mobil
assay
strategi
allow
rapid
identif
b
clade
b
suligoi
roma
propos
new
method
estim
hiv
incid
infect
base
avid
index
hiv
antibodi
pacenti
padova
describ
effect
therapi
differenti
gene
express
profil
provid
evid
proteas
inhibitor
activ
gene
downregul
express
sever
gene
involv
lipid
metabol
induct
adipocyt
differenti
could
basi
lipodystrophi
genoves
roma
describ
molecular
character
hcv
hbv
epidem
northern
italian
dialisi
center
epidem
viral
phylogenet
analysi
show
one
isol
infect
three
four
patient
high
sequenc
homogen
observ
hcv
hbv
isol
acut
patient
comparison
chronic
patient
hear
loss
defect
caus
congenit
hcmv
infect
discuss
barbi
milano
infect
preval
itali
close
lowest
valu
found
literatur
cricca
bologna
describ
pcr
approach
determin
physic
state
viral
load
dna
investig
view
hpv
integr
higher
viral
load
consid
put
earli
marker
hpv
oncogen
progress
chronic
infect
women
detect
swine
enter
calicivirus
italian
farm
evalu
potenti
zoonot
transmiss
virus
discuss
bassi
brescia
therapeut
potenti
transplant
genet
modifi
hematopoiet
stem
cell
success
demonstr
two
differ
form
sever
combin
immunodefici
report
f
mavilio
modena
genet
modif
stem
cell
carri
ex
vivo
transduc
target
cell
viral
vector
carri
therapeut
gene
f
mavilio
also
underlin
risk
insert
oncogenesi
retrovir
vector
verifi
clinic
trial
risk
unaccept
disord
research
need
develop
newer
safer
effici
gene
transfer
vector
clinic
applic
c
ventura
bologna
describ
molecular
dissect
cardiogenesi
embryon
stem
cell
underlin
involv
dynorphin
b
autocrin
intracrin
signal
essenti
cardiogenesi
dynorphin
b
induc
subcellular
redistribut
protein
kinas
c
pkc
remark
increas
nuclear
pkc
activ
g
di
genova
siena
propos
anticanc
vaccin
strategi
prostat
carcinoma
epitheli
carcinoma
express
parathyroid
hormon
relat
protein
author
show
mous
model
intranas
administr
influenza
virosom
iriv
contain
gene
plasmid
induc
specif
ctl
respons
absenc
toxic
andor
autoimmun
vivo
sabbioni
ferrara
describ
applic
adenovir
vector
express
short
hairpin
rna
shrna
suppress
mediat
tumorigen
bkv
adenovir
vector
induc
rna
interfer
revers
oncogen
phenotyp
cancer
cell
vitro
vivo
use
gene
therapi
develop
function
analysi
vector
gene
transfer
report
b
del
santo
pisa
r
franconi
roma
describ
efficaci
intracellular
singl
chain
antibodi
fragment
express
intrabodi
protect
nicotiana
benthamiana
plant
cucumb
mosaic
viru
infect
radaelli
milano
discuss
result
obtain
use
siv
vaccin
describ
high
respons
macaqu
approach
may
realist
approach
immun
therapi
human
immunodefici
viru
type
individu
hepat
c
viru
hcv
envelop
rna
viru
character
high
degre
genet
variabl
studi
genet
variabl
rna
virus
receiv
increas
attent
possibl
link
viral
evolut
diseas
control
prevent
p
farci
cagliari
highlight
main
factor
contribut
genet
variabl
hcv
gener
quasispeci
quasispeci
evolv
earli
cours
hcv
infect
variabl
gene
highest
variabl
detect
domain
gene
hypervari
region
evolv
rapidli
infect
individu
consegu
continu
immun
pressur
host
abrignani
siena
overview
immunolog
aspect
hcv
infect
nicosia
roma
propos
base
hcv
vaccin
capabl
chimpanze
blunt
acut
viremia
protect
acut
chronic
diseas
induc
heterolog
viru
challeng
zanetti
milano
discuss
epidemiolog
prevent
hcv
underlin
import
implement
primari
prevent
measur
reduc
risk
acquiringtransmit
hcv
infect
last
present
p
la
colla
cagliari
propos
novel
ribonucleosid
analogu
potent
antivir
activ
chronic
hcv
infect
fourth
nation
congress
italian
societi
virolog
siv
held
palazzo
del
popolo
orvieto
terni
itali
septemb
istituto
zooprofilattico
sperimental
regioni
lazio
e
toscana
istituto
zooprofilattico
sperimental
dellumbria
e
dell
march
italian
societi
virolog
siv
thank
speaker
particip
import
contribut
oral
poster
session
meet
